Fermenta Biotech
335.60
-6.80(-1.99%)
Market Cap₹987.69 Cr
PE Ratio9.45
IndustryHealthcare
Company Performance:
1D-1.99%
1M-11.54%
6M+24.99%
1Y+8.05%
5Y-8.19%
View Company Insightsright
Latest news about Fermenta Biotech
Fermenta Biotech Reports Strong Q1 EBITDA Growth to 282M Rupees 9 days ago
Fermenta Biotech Limited announced approval of its Q1 unaudited financial results. The company's EBITDA reached 282.00 million rupees, up from 8.00 million rupees in the same period last year. EBITDA margin improved to 20.70% from 1.03%. The board meeting was held on August 12, reviewing both standalone and consolidated operations for the quarter ended June 30. Limited Review Reports were submitted by statutory auditors SRBC & Co. LLP.
Fermenta Biotech Secures European Certification for Vitamin D3 Product, Boosting Global Market Position Jul 29, 2025
Fermenta Biotech Swings to Profit in Q4, Announces Dividend May 29, 2025
Fermenta Biotech Reports Strong Q4 Results, Declares Dividend May 28, 2025